Search research articles
Contact Us
Filters
Showing results (21-30 of 151) with videos related to
Page
of 16
Sort By:
Human Vaccines & Immunotherapeutics
|
October 24, 2018
Decision-making for PCV in adults
John M McLaughlin, David L Swerdlow, Raul E Isturiz, et al.
Infectious Diseases and Therapy
|
February 15, 2021
Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
Heather L Sings, Bradford D Gessner, Matt D Wasserman, et al.
Infectious Diseases and Therapy
|
August 24, 2024
A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'
Hannah R Volkman, Jennifer L Nguyen, Luis Jodar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Evolution of the Meningitis Vaccine Project
Kathleen Tiffay, Luis Jodar, Marie-Paule Kieny, et al.
Lancet Regional Health. Americas
|
February 7, 2022
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis
John M McLaughlin, Farid Khan, Sarah Pugh, et al.
The Lancet. Infectious Diseases
|
January 30, 2021
Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes
Christian Theilacker, Mark A Fletcher, Julia R Spinardi, et al.
Expert Review of Vaccines
|
August 8, 2017
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
Raul Isturiz, Heather L Sings, Betsy Hilton, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
July 25, 2025
Lyme Borreliosis Incidence Across Europe, 2015-2023: A Surveillance-Based Review and Analysis
Alexander Davidson, Julie Davis, Gordon Brestrich, et al.
Vaccines
|
October 26, 2024
Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. <i>Vaccines</i> 2024, <i>12</i>, 434
Hannah R Volkman, Jennifer L Nguyen, Mustapha M Mustapha, et al.
Expert Review of Vaccines
|
February 19, 2021
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia
Bradford D Gessner, Raul Isturiz, Vincenza Snow, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 151) with videos related to
Sort By:
Page
of 16
Human Vaccines & Immunotherapeutics
|
October 24, 2018
Decision-making for PCV in adults
John M McLaughlin, David L Swerdlow, Raul E Isturiz, et al.
Infectious Diseases and Therapy
|
February 15, 2021
Pneumococcal Conjugate Vaccine Impact on Serotype 3: A Review of Surveillance Data
Heather L Sings, Bradford D Gessner, Matt D Wasserman, et al.
Infectious Diseases and Therapy
|
August 24, 2024
A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'
Hannah R Volkman, Jennifer L Nguyen, Luis Jodar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
The Evolution of the Meningitis Vaccine Project
Kathleen Tiffay, Luis Jodar, Marie-Paule Kieny, et al.
Lancet Regional Health. Americas
|
February 7, 2022
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis
John M McLaughlin, Farid Khan, Sarah Pugh, et al.
The Lancet. Infectious Diseases
|
January 30, 2021
Comparing the effect of PCV10 and PCV13 paediatric vaccination programmes
Christian Theilacker, Mark A Fletcher, Julia R Spinardi, et al.
Expert Review of Vaccines
|
August 8, 2017
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
Raul Isturiz, Heather L Sings, Betsy Hilton, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
July 25, 2025
Lyme Borreliosis Incidence Across Europe, 2015-2023: A Surveillance-Based Review and Analysis
Alexander Davidson, Julie Davis, Gordon Brestrich, et al.
Vaccines
|
October 26, 2024
Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. <i>Vaccines</i> 2024, <i>12</i>, 434
Hannah R Volkman, Jennifer L Nguyen, Mustapha M Mustapha, et al.
Expert Review of Vaccines
|
February 19, 2021
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia
Bradford D Gessner, Raul Isturiz, Vincenza Snow, et al.
Page
of 16